Research dives into the link between Alzheimer’s, flavonoids and cannabis

326 0

More studies on cannabis for treating Alzheimer’s helps clear the air on the plant’s benefits

A couple of studies that have been published recently in scientific magazines have demonstrated the connections that might exist between Alzheimer’s disease and both flavonoids and cannabis. One was published in The American Journal of Clinical Nutrition this past April by Oregon State University (OSU), which found that flavonoids are associated with lower risks of Alzheimer’s disease. In the second study, featured in the Journal of Alzheimer’s Disease, it was discovered that small doses of tetrahydrocannabinol (THC) could bring major benefits to patients.

Even though the first study does not provide a solid connection between flavonoids and Alzheimer’s, it does showcase an association between the two. “Evidence suggesting that some flavonoids or flavonoid-rich foods may enhance cognitive function is currently limited, and it is not yet known whether their consumption could lower the risk of cognitive impairments and dementia in humans,” said OSU. The study also added that beyond having preventive effects in front of cognitive impairments in animal models, these compounds are helpful for improving cardiovascular health.

The second study and other evidence regarding the effects of cannabis, specifically THC, are also promising. Last year, The Fresh Toast covered one study that suggested that “THC and [cannabidiol] CBD did the most to prevent learning impairment.” These cannabinoids actually promoted a change in the plaques responsible for building up and causing memory blockages. Another study published in the Journal of Alzheimer’s Disease reported that patients who took small doses of THC were able to reduce the production of proteins (plaque) that are commonly found in the brains of Alzheimer’s patients.